Posts Tagged 'enteropathy'

Daiichi-Sankyo Announces Benicar Settlement in Strongly Worded Press Release

daiichi-sankyo announces benicar settlement“The impact to the financial position of the company is not considered material because, upon presentation of proper claim documentation, the settlement fund is expected to be comprised primarily of proceeds from several of Daiichi Sankyo Group’s insurance companies supplemented with company funds.

Daiichi Sankyo believes that the claims made in this litigation are without merit, and does not admit liability.”

We don’t believe we did anything wrong and it doesn’t matter much anyway because ...

continue reading...

Federal Benicar Lawsuits Selected for Potential Bellwether Trial in MDL

benicar lawsuits selected for federal mdlThe U.S. District Court for the District of New Jersey has announced a pool of 30 federal Benicar lawsuits that will be considered for bellwether trial. The announcement follows a November order detailing how these cases would be randomly selected by the court.

Over 1,100 Benicar lawsuits are pending in a New Jersey multidistrict litigation, according to recent court estimates. Plaintiffs who have filed Benicar lawsuits claim that Japanese pharmaceutical ...

continue reading...

Benicar Lawsuit Depositions Slated to Begin January

benicar lawsuit depositions to begin in 2016Depositions are expected to begin early next year for over 1,000 federal Benicar lawsuits filed by patients who claim the blood pressure drug caused severe gastrointestinal problems. In a recent court order, U.S. Magistrate Judge Joel Schneider scheduled depositions of defendants’ employees to commence on January 18, with two depositions each week until February 26.

Benicar, Daiichi Sankyo’s brand-name olmesartan, was approved in 2002 by the U.S. Food and Drug Administration ...

continue reading...

First Federal Benicar Lawsuit Trial Set for Late 2016

federal benicar lawsuits set to start in late 2016Following a September 30 status conference, the first Benicar multidistrict litigation lawsuit has been scheduled for trial in late 2016, reports the New Jersey Law Journal.

The litigation, overseen by District Judge Michael Schneider in the U.S. District Court for the District of New Jersey, already includes over 1,100 Benicar lawsuits. These have been filed by patients who claim Daiichi Sankyo’s hypertension drug Benicar caused them ...

continue reading...

Benicar Lawsuits Consolidated

benicar lawsuits consolidated into multidistrict litigationThe U.S. Judicial Panel on Multidistrict Litigation has ruled to consolidate lawsuits alleging that Benicar, Daiichi Sankyo’s brand-name olmesartan, can cause serious gastrointestinal issues. According to Reuters, the panel handed down its ruling after a March 26 hearing in the U.S. District Court for the Southern District of California.

Benicar was approved by the U.S. Food and Drug Administration (FDA) in 2002 for use as a blood pressure medication. Since ...

continue reading...

Blood Pressure Medication Linked to Intestinal Issues

Benicar, Azor, Tribenzor among Drugs which May Cause Problems

Benicar has been linked to severe intestinal issues and sprue-like enteropathyAn article recently published in Pharmacy and Therapeutics Journal has linked the drug olmesartan to drug induced sprue-like enteropathy, a condition that results in issues similar to those caused by celiac disease. Olmesartan is a drug used to treat high blood pressure that is marketed under the brand names Benicar, Benicar HCT, Azor, and Tribenzor, as well ...

continue reading...
Page 1 of 4 1234